Herpesvirus infection of target cells is a complex process involving multiple host cell surface
molecules (receptors) and multiple viral envelope glycoproteins. Kaposi's sarcoma …

The establishment of latency is an essential step for the life-long persistent infection and
pathogenesis of Kaposi's sarcoma-associated herpesvirus (KSHV). While the KSHV …

Kaposi's sarcoma herpesvirus (KSHV) is the eighth human herpesvirus discovered in 1994
from Kaposi's sarcoma lesion of an AIDS patient. The strong molecular and epidemiological …

Previously, we identified that both human herpesvirus 6 and human immunodeficiency virus
type 1 Tat were important cofactors that activated lytic cycle replication of Kaposi's sarcoma …

The linkage of Kaposi sarcoma (KS) to infection by a novel human herpesvirus (Kaposi
sarcoma–associated herpesvirus [KSHV]) is one of the great successes of contemporary …

Kaposi's sarcoma-associated herpesvirus (KSHV) is a human oncogenic virus, which
maintains the persistent infection of the host by intermittently reactivating from latently …

Kaposi's sarcoma-associated herpesvirus (KSHV), the most recently identified member of
the herpesvirus family, infects a variety of target cells in vitro and in vivo. This minireview …

Kaposi's sarcoma-associated herpesvirus (KSHV) is tightly linked to at least two
lymphoproliferative disorders, primary effusion lymphoma (PEL) and multicentric …

Kaposi sarcoma–associated (KS-associated) herpesvirus (KSHV) infection is linked to the
development of both KS and several lymphoproliferative diseases. In all cases, the resulting …

The K1 gene product of Kaposi's sarcoma-associated herpesvirus (KSHV) is encoded by the
first open reading frame (ORF) of the viral genome. To investigate the role of the K1 gene …